EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy

Anna K Strosznajder, Sylwia Wójtowicz, Mieszko J Jeżyna, Grace Y Sun, Joanna B Strosznajder

NeuroMolecular Medicine · 2021-03 · 23 (1) · 86-98

DOI: 10.1007/s12017-020-08629-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift NeuroMolecular Medicine, online erschienen am 18.11.2020. Verfasst von Anna K Strosznajder und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Medical University of Bialystok, 1 Kilinskiego st., 15-089, Białystok, Poland. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Mossakowski Medical Research Centre PAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peroxisome proliferator-activated receptor (PPAR) β/δ belongs to the family of hormone and lipid-activated nuclear receptors, which are involved in metabolism of long-chain fatty acids, cholesterol, and sphingolipids. Similar to PPAR-α and PPAR-γ, PPAR-β/δ also acts as a transcription factor activated by dietary lipids and endogenous ligands, such as long-chain saturated and polyunsaturated fatty acids, and selected lipid metabolic products, such as eicosanoids, leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids. Together with other PPARs, PPAR-β/δ displays transcriptional activity through interaction with retinoid X receptor (RXR). In general, PPARs have been shown to regulate cell differentiation, proliferation, and development and significantly modulate glucose, lipid metabolism, mitochondrial function, and biogenesis. PPAR-β/δ appears to play a special role in inflammatory processes and due to its proangiogenic and anti-/pro-carcinogenic properties, this receptor has been considered as a therapeutic target for treating metabolic syndrome, dyslipidemia, carcinogenesis, and diabetes. Until now, most studies were carried out in the peripheral organs, and despite of its presence in brain cells and in different brain regions, its role in neurodegeneration and neuroinflammation remains poorly understood. This review is intended to describe recent insights on the impact of PPAR-β/δ and its novel agonists on neuroinflammation and neurodegenerative disorders, including Alzheimer’s and Parkinson’s, Huntington’s diseases, multiple sclerosis, stroke, and traumatic injury. An important goal is to obtain new insights to better understand the dietary and pharmacological regulations of PPAR-β/δ and to find promising therapeutic strategies that could mitigate these neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBrain IschemiaBrain NeoplasmsDrug Delivery SystemsEndothelial CellsGliomaInflammationLipid MetabolismNeuroblastomaNeurodegenerative DiseasesNeurogliaNeuronsNeuroprotective AgentsOxidative StressPPAR deltaPPAR-betaRetinoid X ReceptorsSignal TransductionTranscription, Genetic

Stichwörter der Autor:innen

AgonistsAlzheimer's diseaseHypoxia/ischemiaLipid metabolismNeurodegenerative disordersNeuroprotectionPPAR delta

Substanzen

Antineoplastic AgentsNeuroprotective AgentsPPAR deltaPPAR-betaRetinoid X Receptors

Autor:innen und Institutionen

  • Faculty of Medicine, Medical University of Bialystok, 1 Kilinskiego st., 15-089, Białystok, Poland.
  • Department of Cellular Signaling, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego st., 02-106, Warsaw, Poland.
  • Biochemistry Department, University of Missouri, Columbia, MO, 65211, USA.
  • Department of Cellular Signaling, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego st., 02-106, Warsaw, Poland. jstrosznajder@imdik.pan.pl.

Förderung

  • Narodowe Centrum Nauki
  • Mossakowski Medical Research Centre PAS

Zitieren

APA

Strosznajder, A. K., Wójtowicz, S., Jeżyna, M. J., Sun, G. Y., & Strosznajder, J. B. (2021). Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. NeuroMolecular Medicine, 23(1), 86-98. https://doi.org/10.1007/s12017-020-08629-9

Vancouver

Strosznajder AK, Wójtowicz S, Jeżyna MJ, Sun GY, Strosznajder JB. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. NeuroMolecular Medicine. 2021;23(1):86-98. doi:10.1007/s12017-020-08629-9

BibTeX
@article{Strosznajder2021,
  author = {Strosznajder, Anna K and Wójtowicz, Sylwia and Jeżyna, Mieszko J and Sun, Grace Y and Strosznajder, Joanna B},
  title = {Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy},
  journal = {NeuroMolecular Medicine},
  year = {2021},
  volume = {23},
  number = {1},
  pages = {86--98},
  doi = {10.1007/s12017-020-08629-9}
}
Kostenlos starten →